• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于推断癌症亚克隆结构的序贯蒙特卡罗算法。

A sequential Monte Carlo algorithm for inference of subclonal structure in cancer.

机构信息

Department of Electrical Engineering, Columbia University, New York, NY, United States of America.

Department of Systems Biology, Columbia University, New York, NY, United States of America.

出版信息

PLoS One. 2019 Jan 25;14(1):e0211213. doi: 10.1371/journal.pone.0211213. eCollection 2019.

DOI:10.1371/journal.pone.0211213
PMID:30682127
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6347199/
Abstract

Tumors are heterogeneous in the sense that they consist of multiple subpopulations of cells, referred to as subclones, each of which is characterized by a distinct profile of genomic variations such as somatic mutations. Inferring the underlying clonal landscape has become an important topic in that it can help in understanding cancer development and progression, and thereby help in improving treatment. We describe a novel state-space model, based on the feature allocation framework and an efficient sequential Monte Carlo (SMC) algorithm, using the somatic mutation data obtained from tumor samples to estimate the number of subclones, as well as their characterization. Our approach, by design, is capable of handling any number of mutations. Via extensive simulations, our method exhibits high accuracy, in most cases, and compares favorably with existing methods. Moreover, we demonstrated the validity of our method through analyzing real tumor samples from patients from multiple cancer types (breast, prostate, and lung). Our results reveal driver mutation events specific to cancer types, and indicate clonal expansion by manual phylogenetic analysis. MATLAB code and datasets are available to download at: https://github.com/moyanre/tumor_clones.

摘要

肿瘤在某种意义上是异质的,因为它们由多个细胞亚群组成,这些亚群被称为亚克隆,每个亚克隆都具有独特的基因组变异特征,如体细胞突变。推断潜在的克隆景观已成为一个重要的研究课题,因为它有助于了解癌症的发展和进展,从而有助于改善治疗效果。我们描述了一种新的状态空间模型,该模型基于特征分配框架和高效的序列蒙特卡罗(SMC)算法,使用从肿瘤样本中获得的体细胞突变数据来估计亚克隆的数量及其特征。我们的方法可以设计处理任意数量的突变。通过广泛的模拟,我们的方法在大多数情况下具有很高的准确性,并与现有方法相比具有优势。此外,我们通过分析来自多种癌症类型(乳腺、前列腺和肺)患者的真实肿瘤样本验证了我们方法的有效性。我们的结果揭示了特定于癌症类型的驱动突变事件,并通过手动系统发育分析表明了克隆扩张。MATLAB 代码和数据集可在以下网址下载:https://github.com/moyanre/tumor_clones。

相似文献

1
A sequential Monte Carlo algorithm for inference of subclonal structure in cancer.一种用于推断癌症亚克隆结构的序贯蒙特卡罗算法。
PLoS One. 2019 Jan 25;14(1):e0211213. doi: 10.1371/journal.pone.0211213. eCollection 2019.
2
Characterizing Intra-Tumor Heterogeneity From Somatic Mutations Without Copy-Neutral Assumption.不基于拷贝数中性假设的肿瘤内体细胞突变异质性特征分析。
IEEE/ACM Trans Comput Biol Bioinform. 2021 Nov-Dec;18(6):2271-2280. doi: 10.1109/TCBB.2020.2973635. Epub 2021 Dec 8.
3
SeqClone: sequential Monte Carlo based inference of tumor subclones.SeqClone:基于序贯蒙特卡罗的肿瘤亚克隆推断。
BMC Bioinformatics. 2019 Jan 5;20(1):6. doi: 10.1186/s12859-018-2562-y.
4
A sequential Monte Carlo approach to gene expression deconvolution.一种用于基因表达反卷积的序贯蒙特卡罗方法。
PLoS One. 2017 Oct 19;12(10):e0186167. doi: 10.1371/journal.pone.0186167. eCollection 2017.
5
BAMSE: Bayesian model selection for tumor phylogeny inference among multiple samples.BAMSE:用于在多个样本中推断肿瘤系统发育的贝叶斯模型选择。
BMC Bioinformatics. 2019 Jun 6;20(Suppl 11):282. doi: 10.1186/s12859-019-2824-3.
6
Reconstructing tumor evolutionary histories and clone trees in polynomial-time with SubMARine.使用SubMARine在多项式时间内重建肿瘤进化历史和克隆树。
PLoS Comput Biol. 2021 Jan 19;17(1):e1008400. doi: 10.1371/journal.pcbi.1008400. eCollection 2021 Jan.
7
QuaDMutEx: quadratic driver mutation explorer.QuaDMutEx:二次驱动突变探索器。
BMC Bioinformatics. 2017 Oct 24;18(1):458. doi: 10.1186/s12859-017-1869-4.
8
Joint haplotype assembly and genotype calling via sequential Monte Carlo algorithm.通过序贯蒙特卡罗算法进行联合单倍型组装和基因型分型
BMC Bioinformatics. 2015 Jul 16;16:223. doi: 10.1186/s12859-015-0651-8.
9
PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors.PhyloWGS:从肿瘤全基因组测序中重建亚克隆组成与进化
Genome Biol. 2015 Feb 13;16(1):35. doi: 10.1186/s13059-015-0602-8.
10
PhySigs: Phylogenetic Inference of Mutational Signature Dynamics.PhySigs:突变特征动态的系统发育推断。
Pac Symp Biocomput. 2020;25:226-237.

本文引用的文献

1
Characterization of tumor heterogeneity by latent haplotypes: a sequential Monte Carlo approach.通过潜在单倍型表征肿瘤异质性:一种序贯蒙特卡罗方法。
PeerJ. 2018 May 30;6:e4838. doi: 10.7717/peerj.4838. eCollection 2018.
2
Universal Patterns of Selection in Cancer and Somatic Tissues.癌症和体细胞组织中的普遍选择模式。
Cell. 2017 Nov 16;171(5):1029-1041.e21. doi: 10.1016/j.cell.2017.09.042. Epub 2017 Oct 19.
3
A sequential Monte Carlo approach to gene expression deconvolution.一种用于基因表达反卷积的序贯蒙特卡罗方法。
PLoS One. 2017 Oct 19;12(10):e0186167. doi: 10.1371/journal.pone.0186167. eCollection 2017.
4
AACR Project GENIE: Powering Precision Medicine through an International Consortium.美国癌症研究协会(AACR)项目GENIE:通过国际联盟推动精准医学发展。
Cancer Discov. 2017 Aug;7(8):818-831. doi: 10.1158/2159-8290.CD-17-0151. Epub 2017 Jun 1.
5
Tracking the Evolution of Non-Small-Cell Lung Cancer.跟踪非小细胞肺癌的演变。
N Engl J Med. 2017 Jun 1;376(22):2109-2121. doi: 10.1056/NEJMoa1616288. Epub 2017 Apr 26.
6
Reverse engineering gene regulatory networks from measurement with missing values.从存在缺失值的测量数据中反向工程基因调控网络。
EURASIP J Bioinform Syst Biol. 2017 Jan 10;2017(1):2. doi: 10.1186/s13637-016-0055-8. eCollection 2016 Dec.
7
AKT1 (E17K) mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection.乳腺癌中AKT1(E17K)突变分析:患病率、并发致癌改变及基于血液的检测
BMC Cancer. 2016 Aug 11;16:622. doi: 10.1186/s12885-016-2626-1.
8
Landscape of somatic mutations in 560 breast cancer whole-genome sequences.560例乳腺癌全基因组序列中的体细胞突变图谱。
Nature. 2016 Jun 2;534(7605):47-54. doi: 10.1038/nature17676. Epub 2016 May 2.
9
Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases.伴有EGFR、KRAS和ALK突变的非小细胞肺癌:12例临床病理特征
J Pathol Transl Med. 2016 May;50(3):197-203. doi: 10.4132/jptm.2016.03.09. Epub 2016 Apr 18.
10
Mutation of genes of the PI3K/AKT pathway in breast cancer supports their potential importance as biomarker for breast cancer aggressiveness.乳腺癌中PI3K/AKT信号通路基因的突变支持了它们作为乳腺癌侵袭性生物标志物的潜在重要性。
Virchows Arch. 2016 Jul;469(1):35-43. doi: 10.1007/s00428-016-1938-5. Epub 2016 Apr 8.